Cite
HARVARD Citation
Fernández-Gutiérrez, J. et al. (2022). High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma. Hematology. 27 (1), pp. 449-455. [Online].